Literature DB >> 24094631

Registration accuracy and image quality of time averaged mid-position CT scans for liver SBRT.

Matthijs F Kruis1, Jeroen B van de Kamer, Jan-Jakob Sonke, Edwin P M Jansen, Marcel van Herk.   

Abstract

PURPOSE AND
BACKGROUND: The purpose was to validate the accuracy of motion models derived from deformable registration from four-dimensional computed tomography (4DCT) and breath-hold contrast enhanced computed tomography (BHCCT) scans for liver SBRT. Additionally, the image quality of the time averaged mid-position (MidP) CT constructed using the detected motion model was assessed.
MATERIALS AND METHODS: 4DCT and BHCCT liver scans of 11 patients were acquired with 1 or 2 fiducial markers. Using parametric sampling the markers were digitally removed. Phase-based optical flow was used to register the 4D frames and the BHCCT, and create MidP data. We compared the deformable registration of the markerless scans with the actual displacement of the markers to assess registration accuracy. The noise levels of the MidP scans were compared to those of the 4DCT and BHCCT data.
RESULTS: We found an average misregistration of 1.8mm (± 0.5mm). The constructed MidPCT scan contained around three times less noise than the original 4D scan. The residual error between the MidPCT and the BHCCT was 3.0mm (± 0.9 mm).
CONCLUSIONS: High precision deformable image registration of 4DCT and BHCCT liver cancer patients was achieved and used to create motion compensated MidPCT scans, with increased contrast-to-noise (CNR) levels. This improved visualisation of tumours and anatomy, facilitates radiotherapy treatment planning.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  4D CT registration mid-position liver SBRT

Mesh:

Year:  2013        PMID: 24094631     DOI: 10.1016/j.radonc.2013.08.047

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

1.  Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy.

Authors:  Florian Sterzing; Thomas B Brunner; Iris Ernst; Wolfgang W Baus; Burkhard Greve; Klaus Herfarth; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2014-08-05       Impact factor: 3.621

2.  Stereotactic Ablative Radiotherapy Using CALYPSO® Extracranial Tracking for Intrafractional Tumor Motion Management-A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective Study.

Authors:  Hrvoje Kaučić; Domagoj Kosmina; Dragan Schwarz; Andreas Mack; Hrvoje Šobat; Adlan Čehobašić; Vanda Leipold; Iva Andrašek; Asmir Avdičević; Mihaela Mlinarić
Journal:  Cancers (Basel)       Date:  2022-05-29       Impact factor: 6.575

3.  Dose escalated liver stereotactic body radiation therapy at the mean respiratory position.

Authors:  Michael Velec; Joanne L Moseley; Laura A Dawson; Kristy K Brock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-08       Impact factor: 7.038

Review 4.  The developing role of FDG PET imaging for prognostication and radiotherapy target volume delineation in non-small cell lung cancer.

Authors:  Tom Konert; Jeroen B van de Kamer; Jan-Jakob Sonke; Wouter V Vogel
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

5.  Motion-compensated FDG PET/CT for oesophageal cancer.

Authors:  Francine E M Voncken; Erik Vegt; Johanna W van Sandick; Jolanda M van Dieren; Cecile Grootscholten; Annemarieke Bartels-Rutten; Steven L Takken; Jan-Jakob Sonke; Jeroen B van de Kamer; Berthe M P Aleman
Journal:  Strahlenther Onkol       Date:  2021-04-07       Impact factor: 3.621

6.  Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.

Authors:  Markus Oechsner; Leonhard Odersky; Johannes Berndt; Stephanie Elisabeth Combs; Jan Jakob Wilkens; Marciana Nona Duma
Journal:  Radiat Oncol       Date:  2015-12-01       Impact factor: 3.481

7.  The advantage of iron-containing fiducial markers placed with a thin needle for radiotherapy of liver cancer in terms of visualization on MRI: an initial experience of Gold Anchor.

Authors:  Osamu Tanaka; Yoichi Nishigaki; Hideki Hayashi; Takayoshi Iida; Takamasa Yokoyama; Eiji Takenaka; Eiichi Yama; Eiichi Tomita
Journal:  Radiol Case Rep       Date:  2017-04-12

8.  Clinical evaluation of respiration-induced attenuation uncertainties in pulmonary 3D PET/CT.

Authors:  Matthijs F Kruis; Jeroen B van de Kamer; Wouter V Vogel; José Sa Belderbos; Jan-Jakob Sonke; Marcel van Herk
Journal:  EJNMMI Phys       Date:  2015-02-24

9.  High versus low dose Stereotactic Body Radiation Therapy for hepatic metastases.

Authors:  Esther N D Kok; Edwin P M Jansen; Birthe C Heeres; Niels F M Kok; Tomas Janssen; Erik van Werkhoven; Fay R K Sanders; Theodore J M Ruers; Marlies E Nowee; Koert F D Kuhlmann
Journal:  Clin Transl Radiat Oncol       Date:  2019-11-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.